Search

Your search keyword '"Nielsen F.C."' showing total 133 results

Search Constraints

Start Over You searched for: Author "Nielsen F.C." Remove constraint Author: "Nielsen F.C."
133 results on '"Nielsen F.C."'

Search Results

2. 55P Potential benefits of extensive genomic analysis in patients with KRAS mutated solid tumors: Concurrent alterations and potential targets

3. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

6. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

7. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

9. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

10. The spectrum of fancm protein truncating variants in European breast cancer cases.

11. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

12. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

13. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

14. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

17. Survival and characteristics of 772 patients with oropharyngeal cancer and specific human papillomavirus genotypes: A Danish population-based study from 2011-2017

19. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

20. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

21. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

22. Shared heritability and functional enrichment across six solid cancers.

23. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

24. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

26. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

27. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

28. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

29. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

30. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer

35. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.

36. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

37. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

38. Characterization of MYG1 gene and protein: Subcellular distribution and function

39. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

41. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

42. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

44. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1

45. Ancient human genome sequence of an extinct Palaeo-Eskimo

46. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling

47. [Pharmacogenetics and tailored drug therapy]

48. A common Greenlandic Inuit BRCA1 RING domain founder mutation

49. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes

Catalog

Books, media, physical & digital resources